Sanofi signs U.S. rights deal with Roche for flu treatment Tamiflu

[July 23, 2019]  PARIS (Reuters) - French drugs and healthcare group Sanofi <SASY.PA> said on Tuesday it had signed a rights deal with Roche <ROG.S> for the 'Tamiflu' product in the United States.

The deal will give Sanofi exclusive U.S. over-the-counter (OTC) rights to Tamiflu, which is used for the prevention and treatment of flu.

"This is a strategic and important transaction for us as we strive to continually bring innovations to the market," said Alan Main, executive vice president of Sanofi's consumer healthcare division, in a statement.

(Reporting by Sudip Kar-Gupta; Editing by Subhranshu Sahu)

[© 2019 Thomson Reuters. All rights reserved.]

Copyright 2019 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.